Search results
Why the Quinn Priester-Nick Yorke trade is a win for Red Sox
NBC Sports Boston· 30 minutes agoWhy the Quinn Priester-Nick Yorke trade is a win for Red Sox originally appeared on NBC Sports...
Alzheimer’s Disease: Some trials to watch over the next year
Clinical Trials Arena· 4 hours agoImage credit: GlobalData Despite the success, concerns remain about amyloid treatments Despite the...
Paris Olympics 2024 India Schedule Day 4: Full list of events and medal match on 30 July
Firstpost· 3 hours agoParis Olympics 2024 India Schedule Day 4: Manu Bhaker will have another chance to win a medal for...
EU CHMP snubs Biogen and Eisai’s Alzheimer’s therapy Leqembi
Pharmaceutical Technology· 3 hours agoEisai was quick to add that the company plans to re-examine the CHMP opinion. The committee was...
Alzheimer’s: drug delivery and the blood brain barrier conundrum
Clinical Trials Arena· 4 hours agoHowever, higher doses of medications can create toxicity or side effects for the rest of the body....
Paris Olympic Games 2024, India's July 30 Full Schedule: List Of Events, Timings In IST & More
Latest India News· 4 hours agoIndia has so far won just one medal in shooting through Manu Bhaker in the women’s 10m air pistol...
Paris Olympics: Manu-Sarabjot aim for bronze on Day 4 of competitions
Daiji World· 2 hours agoParis, Jul 29 (IANS): Sharpshooter Manu Bhaker will take aim along with her partner Sarabjot Singh...
Olympics: Check out India's schedule on July 30, 2024
rediff.com· 4 hours agoManu Bhaker will be aiming to win India's second medal at the Paris Olympic Games when she and...
Longeveron’s Phase IIa Alzheimer’s therapy trial meets efficacy endpoints
Clinical Trials Arena· 11 hours agoFurthermore, Lomecel-B was found to be safe for both single and multiple dosing regimens, without...
Paris Olympics 2024 Day 4 (July 30): India's Full Schedule | Paris Olympics 2024 News - Times of...
The Times of India· 3 hours agoNEW DELHI: A confident Manu Bhaker has positioned herself for a chance at a second Olympic medal, as...